| Blog results | Results 1 - 10 of about 5,227 for simvastatin patent. (0.32 seconds) |
| Sorted by relevance Sort by date |
| 25 Nov 2009 by Naomi Freundlich In the nearly $20 billion market for cholesterol-lowering drugs, Vytorin—a combination of simvastin, an off-patent statin and Zetia, a proprietary drug that is designed to inhibit the body's absorption of cholesterol from food—is one ... Health Beat - http://www.healthbeatblog.com/ - References |
| 13 Nov 2009 by Jacob Goldstein Vytorin is actually a combination of two cholesterol drugs — simvastatin, a generic statin, and the patent-protected Zetia; the patients in one arm of this trial were taking a combination of a statin and Zetia. Zetia and Vytorin are a ... WSJ.com: Health Blog - http://blogs.wsj.com/health/ - References [ More results from WSJ.com: Health Blog ] |
| 27 Oct 2009 Using Generic Statins. A generic drug is a copy of a brand drug whose patent has expired. Lovastatin, pravastatin, and simvastatin are generic versions of Mevacor, Pravachol and Zocor. Generic drugs are less expensive. ... Suite101: Health & Wellness Articles - http://www.suite101.com/healthandwellness/ |
| 1 Aug 2006 by rcentor When Merck's blockbuster cholesterol-lowering agent, Zocor (simvastatin), lost patent protection last month, the move was expected to have a large impact on the statin market, affecting sales of not just Zocor but also the other major ... DB's Medical Rants - http://www.medrants.com/ [ More results from DB's Medical Rants ] |
| 17 Nov 2009 by Fernando Comas Vytorin is actually a combination of two cholesterol drugs — the generic simvastatin and the patent-protected Zetia. Zetia and Vytorin are a huge franchise, with projected sales of around $4 billion this year. It's clear that Vytorin ... PHARMACOSERÍAS Marketing Farmacéutico/Pharmac... - http://pharmacoserias.blogspot.com/ - References |
| 7 Jul 2009 Guess you know we were happy when that happened (my mother takes Simvastatin). Eisai, the patent holder on Aricept, is quickly preparing to bring a new version of Aricept to the market. The new Aricept is an extended release (Donepezil ... Alzheimer's Reading Room - http://www.alzheimersreadingroom.com/ |
| 16 Nov 2009 But it still shows Niaspan as clearly superior to Zetia, and it makes a person wonder if taking Zetia is basically an expensive way to take a possibly-inadequate dose of simvastatin. In a way, the relatively small size .... Why didn't the researchers include a niacin+ezetimibe arm? I think because there was too great a risk of additive benefit. And since Merck/Schering still holds the patent on ezetimibe, why should Abbott risk finding such as result? Permalink to Comment ... In the Pipeline - http://pipeline.corante.com/ - References [ More results from In the Pipeline ] |
| 9 Nov 2009 by AbiK The latest flurry of statin drug-related news could substitute for your afternoon tv soap fix—except there's a very real-life drama being played out. It's full of intrigue and false promises. ... the horror of the realization that Merck seemingly has squat sitting in its back pocket to push Zetia now that the Zetia/Lipitor combo they were hoping to market has been refused by the FDA (Lipitor, currently marketed by Pfizer, is due to lose its patent protection as of 2011). ... lawyersandsettlements.com - http://www.lawyersandsettlements.com/blog/ |
| 17 Sep 2009 The present invention generally relates to a stable pharmaceutical composition that does not have a film coating which contains simvastatin, ezetimibe or pharmaceutically-acceptable salts thereof, and ascorbic acid. Boliven Search: data_source:USPTO - http://www.boliven.com/ |
| 23 Aug 2007 U.S. Patent No. 4444784 discloses a process for the preparation of Simvastatin, which involves indirect methylation of the C-8 side chain of lovastatin through several chemical steps: deesterification of the whole 2-methylbutyrate side ... IP.com Prior Art Database - http://www.priorartdatabase.com/ [ More results from IP.com Prior Art Database ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |